ScholarIQanswers from OpenAlex

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1

PaperCitations, authors & open-access status

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1 is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1 have?

ScholarIQcitation count

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1 has 452 citations in the OpenAlex counts ScholarIQ stores.

When was Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1 published?

ScholarIQyear

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1 has 1998 year in the ScholarIQ index.

What is the open-access status of Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1?

ScholarIQoa status

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1 has closed oa status in the ScholarIQ index.

What is the DOI of Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1?

ScholarIQdoi

The DOI for Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1 is on the source record.

What is the PMID of Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1?

ScholarIQpmid

The PMID for Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1 is on the source record.

What is the OpenAlex record for Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1?

ScholarIQopenalex

The OpenAlex for Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1 is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial